Home LiteratureArticle Details
PMID: 10476804 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.

Investigative ophthalmology & visual science ·Vol. 40 ·No. 10 ·1999-09-00 ·Pages 2367-75

Kamei M, Hollyfield JG

Abstract

To assess the distribution, content, and function of tissue inhibitor of metalloproteinases (TIMP)-3 during aging in normal eyes for comparison with the levels observed in eyes with age-related macular degeneration (AMD). Donor tissues analyzed included 36 normal eyes (14-96 years old) and 15 AMD eyes (74 -98 years old). A tissue strip including the fovea was used for immunohistochemistry. Western blot analysis was performed on extracts of the retinal pigment epithelium (RPE)- choroid complex from the posterior part of each eye. Immunoreactivity of TIMP-3 bands in each western blot was densitometrically quantitated. The inhibitory function of TIMP-3 was evaluated with reverse zymography. TIMP-3 was present uniformly across Bruch's membrane in the normal samples. In samples from donors more than 50 years of age, immunostaining was intense. TIMP-3 content ranged from 92 to 1061 ng/cm2 and increased with age (r = 0.66). In AMD eyes, TIMP-3 distribution in Bruch's membrane was abundant in areas of continuous soft drusen but absent in areas below RPE atrophy. TIMP-3 levels in AMD eyes were significantly higher than in age-matched normal eyes (577 versus 877 ng/cm2; P = 0.009). Inhibitory activity correlated well with TIMP-3 content (r = 0.82) and was also significantly higher in AMD eyes than in age-matched normal eyes (P < 0.001). During normal aging, TIMP-3 content in Bruch's membrane of the macula shows a significant increase. TIMP-3 content in AMD eyes was elevated relative to that of age-matched normal eyes. Higher levels of TIMP-3 may contribute to the thickening of Bruch's membrane observed in AMD.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Aging/metabolism Blotting, Western Bruch Membrane/chemistry,metabolism Female Humans Immunoenzyme Techniques Macular Degeneration/metabolism Male Middle Aged Protease Inhibitors/analysis,metabolism Tissue Donors Tissue Inhibitor of Metalloproteinase-3/analysis,metabolism
Chemicals
Protease Inhibitors Tissue Inhibitor of Metalloproteinase-3
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kamei M
The Eye Institute, The Cleveland Clinic Foundation, Ohio 44195, USA. kameim@cesmtp.ccf.org
Hollyfield J G
Article Info
Journal
Investigative ophthalmology & visual science
Abbr.
Invest Ophthalmol Vis Sci
ISSN
0146-0404
Published
1999-09-00
Pages
2367-75
Language
English
Region
United States
NLM ID
7703701
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com